SILVERARC CAPITAL MANAGEMENT, LLC
Position in COGT — Cogent Biosciences, Inc.
CIK 1816307
BOSTON, MA
Position in COGT
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$49,563,360
-$1,019,774 QoQ
Shares Held
1,280,707
-2.5% QoQ
Ownership
0.738%
of shares outstanding
% of Portfolio
5.52%
of 13F equity value
Holder Rank
#34
of 321 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in COGT Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SILVERARC CAPITAL MANAGEMENT, LLC holds $802,586,993 across 53 Biotechnology names. COGT ranks #3 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
206,234 | $55,006,732 | |
| 2 | CELC |
Celcuity Inc.
|
500,996 | $52,414,201 | |
| 3 | COGT |
Cogent Biosciences, Inc.
This page
|
1,280,707 | $49,563,360 | |
| 4 | URGN |
UroGen Pharma Ltd.
|
1,301,979 | $47,912,827 | |
| 5 | IMNM |
Immunome Inc.
|
2,017,009 | $42,740,420 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
390,000 | $38,017,200 | |
| 7 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
311,461 | $34,581,514 | |
| 8 | ORKA |
Oruka Therapeutics, Inc.
|
352,802 | $33,576,166 |
All Filings in COGT
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $49,563,360 | 1,280,707 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $50,583,134 | 1,314,189 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $44,231,422 | 1,245,254 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $11,704,477 | 815,075 | Shares | Sole | 2025-11-12 | |
| 2024-12-31 | $7,184,868 | 921,137 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $13,190,709 | 1,221,362 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $10,168,384 | 1,206,214 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $6,966,402 | 1,036,667 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $5,684,478 | 966,748 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $6,350,877 | 651,372 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $7,340,800 | 620,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $6,250,258 | 579,264 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,069,240 | 179,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,050,591 | 606,608 | Shares | Sole | 2022-10-28 | |
| 2022-06-30 | $7,405,005 | 820,954 | Shares | Sole | 2022-07-25 | |
| 2022-03-31 | $4,297,005 | 573,699 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $7,301,022 | 850,935 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $5,701,139 | 677,900 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $1,607,766 | 198,245 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $1,053,600 | 120,000 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $2,639,791 | 235,066 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||